Thrombocytopenia: the good, the bad and the ugly

16Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

New thrombocytopenia may be associated with a variety of conditions and diagnosis can be challenging. Presentation can vary from life-threatening bleeding or thrombosis to an incidental finding in an asymptomatic patient. New thrombocytopenia requires urgent investigation. Investigations are mainly guided by findings from the clinical history, physical examination, full blood count and blood film analysis. Aside from the actively bleeding patient, rare but life-threatening causes of thrombocytopenia must be identified early as they require urgent treatment. These include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, suspicion of new acute promyelocytic leukaemia, and vaccine-induced prothrombotic immune thrombocytopenia. Here, we discuss how to approach a patient with new thrombocytopenia, along with key differentials not to be missed.

Cite

CITATION STYLE

APA

Ashworth, I., Thielemans, L., & Chevassut, T. (2022). Thrombocytopenia: the good, the bad and the ugly. Clinical Medicine, Journal of the Royal College of Physicians of London, 22(3), 214–217. https://doi.org/10.7861/clinmed.2022-0146

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free